| Maryann Phillippi, MD | |
|
601 John St Ste N1200, Kalamazoo, MI 49007-5318 | |
| (269) 341-7887 | |
| Not Available |
| Full Name | Maryann Phillippi |
|---|---|
| Gender | Female |
| Speciality | Obstetrics & Gynecology |
| Location | 601 John St Ste N1200, Kalamazoo, Michigan |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1649247792 | NPI | - | NPPES |
| 036100368 | Medicaid | IL |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 036100368 (Illinois) | Primary |
| Entity Name | Bronson Methodist Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1417961137 PECOS PAC ID: 0244148633 Enrollment ID: O20031208000832 |
News Archive
pSivida Corp., a leader in the development of tiny, sustained-release drug delivery technologies, with two of the only three ophthalmic sustained-release delivery products approved by the FDA for treatment of back of the eye diseases, announced that its chief executive officer, Dr. Paul Ashton, will discuss ocular drug delivery in diabetic retinopathy during a presentation at the 6th Annual Diabetes Conference in London, on Friday, January 22.
New research by scientists at The University of Texas Health Science Center at Houston (UTHealth) and The University of Texas M. D. Anderson Cancer Center could make it easier for patients to use a family of promising experimental cancer therapeutics known as small interfering RNA (siRNA).
A new technique aimed at directly controlling the expression of genes by turning them on or off at the DNA level could lead to drugs for the treatment or cure of many diseases, say researchers at UT Southwestern Medical Center.
A new study shows that diuretic pill Inspra (generic – Eplerenone) cuts down the risk of death and hospitalization among people with mild heart failure. The drug that is widely used to treat advanced heart failure, also has value for people with mild disease, says lead researcher Faiez Zannad, of Nancy University in Nancy, France. The results were reported at the American Heart Association's annual meeting and published simultaneously online in the New England Journal of Medicine.
In a progress report, Obama administration officials are predicting that, despite fixes that have been made, one in five people won't be able to buy health insurance via the online process. Still, the pace of enrollments has more than doubled, the New York Times reports.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Maryann Phillippi, MD 601 John Street, Box 39, Kalamazoo, MI 49007 Ph: () - | Maryann Phillippi, MD 601 John St Ste N1200, Kalamazoo, MI 49007-5318 Ph: (269) 341-7887 |
News Archive
pSivida Corp., a leader in the development of tiny, sustained-release drug delivery technologies, with two of the only three ophthalmic sustained-release delivery products approved by the FDA for treatment of back of the eye diseases, announced that its chief executive officer, Dr. Paul Ashton, will discuss ocular drug delivery in diabetic retinopathy during a presentation at the 6th Annual Diabetes Conference in London, on Friday, January 22.
New research by scientists at The University of Texas Health Science Center at Houston (UTHealth) and The University of Texas M. D. Anderson Cancer Center could make it easier for patients to use a family of promising experimental cancer therapeutics known as small interfering RNA (siRNA).
A new technique aimed at directly controlling the expression of genes by turning them on or off at the DNA level could lead to drugs for the treatment or cure of many diseases, say researchers at UT Southwestern Medical Center.
A new study shows that diuretic pill Inspra (generic – Eplerenone) cuts down the risk of death and hospitalization among people with mild heart failure. The drug that is widely used to treat advanced heart failure, also has value for people with mild disease, says lead researcher Faiez Zannad, of Nancy University in Nancy, France. The results were reported at the American Heart Association's annual meeting and published simultaneously online in the New England Journal of Medicine.
In a progress report, Obama administration officials are predicting that, despite fixes that have been made, one in five people won't be able to buy health insurance via the online process. Still, the pace of enrollments has more than doubled, the New York Times reports.
› Verified 6 days ago
Dr. Amanda Keating Walker, D.O. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 601 John St, Suite N1200, Kalamazoo, MI 49007 Phone: 269-341-7979 Fax: 269-341-6261 | |
Paul I Berkowitz, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 601 John Street, Box 42, Kalamazoo, MI 49007 Phone: 269-341-6417 Fax: 269-341-8743 | |
Malcolm Hamilton, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 601 John St, Suite N1200, Kalamazoo, MI 49007 Phone: 269-341-7979 Fax: 269-341-6261 | |
Dr. Benjamin Baines Mize, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 200 N Park St, Kalamazoo, MI 49007 Phone: 269-382-2500 Fax: 269-384-8617 | |
Jordan Wroblewski, Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1521 Gull Rd, Kalamazoo, MI 49048 Phone: 269-226-6000 | |
Dr. Wendy L Bauer, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 2854 S 11th St, Kalamazoo, MI 49009 Phone: 269-345-6197 Fax: 269-345-9734 | |
Brandi L Boone, CNM Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 601 John St, Suite N1200, Kalamazoo, MI 49007 Phone: 269-341-7979 Fax: 269-341-6261 |